Solid Biosciences Inc (SLDB)
10.10
-0.13
(-1.27%)
USD |
NASDAQ |
May 03, 16:00
10.18
+0.08
(+0.84%)
After-Hours: 20:00
Solid Biosciences Price to Book Value: 3.023 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.023 |
| May 02, 2024 | 3.062 |
| May 01, 2024 | 2.856 |
| April 30, 2024 | 2.655 |
| April 29, 2024 | 2.631 |
| April 26, 2024 | 2.688 |
| April 25, 2024 | 2.556 |
| April 24, 2024 | 2.625 |
| April 23, 2024 | 2.727 |
| April 22, 2024 | 2.706 |
| April 19, 2024 | 2.604 |
| April 18, 2024 | 2.772 |
| April 17, 2024 | 2.990 |
| April 16, 2024 | 2.940 |
| April 15, 2024 | 2.993 |
| April 12, 2024 | 3.102 |
| April 11, 2024 | 3.189 |
| April 10, 2024 | 3.240 |
| April 09, 2024 | 3.458 |
| April 08, 2024 | 3.563 |
| April 05, 2024 | 3.637 |
| April 04, 2024 | 3.703 |
| April 03, 2024 | 3.745 |
| April 02, 2024 | 3.619 |
| April 01, 2024 | 3.721 |
| Date | Value |
|---|---|
| March 28, 2024 | 3.976 |
| March 27, 2024 | 4.254 |
| March 26, 2024 | 4.051 |
| March 25, 2024 | 4.054 |
| March 22, 2024 | 4.105 |
| March 21, 2024 | 3.767 |
| March 20, 2024 | 3.961 |
| March 19, 2024 | 4.403 |
| March 18, 2024 | 3.988 |
| March 15, 2024 | 3.905 |
| March 14, 2024 | 3.666 |
| March 13, 2024 | 3.651 |
| March 12, 2024 | 3.403 |
| March 11, 2024 | 3.406 |
| March 08, 2024 | 3.326 |
| March 07, 2024 | 3.033 |
| March 06, 2024 | 2.812 |
| March 05, 2024 | 2.836 |
| March 04, 2024 | 2.870 |
| March 01, 2024 | 2.893 |
| February 29, 2024 | 2.781 |
| February 28, 2024 | 2.799 |
| February 27, 2024 | 2.985 |
| February 26, 2024 | 2.813 |
| February 23, 2024 | 2.964 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.26
Minimum
May 11 2022
29.71
Maximum
Dec 30 2020
2.243
Average
1.404
Median
Mar 27 2020
Price to Book Value Benchmarks
| Sarepta Therapeutics Inc | 13.14 |
| PTC Therapeutics Inc | -- |
| Capricor Therapeutics Inc | 7.624 |
| Perspective Therapeutics Inc | 14.13 |
| Electromed Inc | 3.946 |
Price to Book Value Related Metrics
| PS Ratio | 13.58 |
| Price | 10.10 |
| Earnings Yield | -47.92% |
| Market Cap | 382.39M |